Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 83,469 |
|
|||||
| News | - | ||||||
| Day High | 0.8977 | Low High |
|||||
| Day Low | 0.8015 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aligos Therapeutics Inc | ALGS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.0453 | 5.66% | 0.8463 | 14:43:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.8015 | 0.8015 | 0.8977 | 0.801 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 250 | 83,469 | $ 0.8539106 | $ 71,275 | - | 0.5388 - 1.38 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:43:01 | 115 | $ 0.8463 | USD |
Aligos Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 65.07M | 75.67M | - | 15.53M | -87.68M | -1.16 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Aligos Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALGS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.891 | 0.90 | 0.73 | 0.7982234 | 239,226 | -0.0447 | -5.02% |
| 1 Month | 0.95 | 1.10 | 0.73 | 0.9609671 | 337,827 | -0.1037 | -10.92% |
| 3 Months | 0.69 | 1.20 | 0.62 | 0.8936709 | 404,380 | 0.1563 | 22.65% |
| 6 Months | 0.76 | 1.20 | 0.5388 | 0.7837397 | 347,359 | 0.0863 | 11.36% |
| 1 Year | 1.03 | 1.38 | 0.5388 | 0.8702961 | 240,720 | -0.1837 | -17.83% |
| 3 Years | 26.41 | 34.31 | 0.5388 | 4.58 | 255,698 | -25.56 | -96.80% |
| 5 Years | 14.74 | 37.5099 | 0.5388 | 6.07 | 238,170 | -13.89 | -94.26% |
Aligos Therapeutics Description
| Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others. |
